Free Trial

Christopher John Blaine Fitzgerald Sells 2,177 Shares of Kinaxis Inc. (TSE:KXS) Stock

Kinaxis logo with Computer and Technology background
Remove Ads

Kinaxis Inc. (TSE:KXS - Get Free Report) Senior Officer Christopher John Blaine Fitzgerald sold 2,177 shares of the business's stock in a transaction on Thursday, March 13th. The shares were sold at an average price of C$156.26, for a total transaction of C$340,172.58.

Kinaxis Price Performance

Shares of Kinaxis stock traded down C$2.81 during trading hours on Tuesday, reaching C$156.78. The stock had a trading volume of 51,019 shares, compared to its average volume of 90,792. The stock's 50 day moving average is C$165.82 and its 200 day moving average is C$165.33. The firm has a market capitalization of C$3.15 billion, a PE ratio of 155.60, a PEG ratio of 3.60 and a beta of 0.78. Kinaxis Inc. has a twelve month low of C$132.93 and a twelve month high of C$190.17. The company has a current ratio of 1.89, a quick ratio of 2.29 and a debt-to-equity ratio of 12.12.

Wall Street Analysts Forecast Growth

Separately, CIBC decreased their target price on shares of Kinaxis from C$175.00 to C$170.00 in a research report on Friday, February 28th. One analyst has rated the stock with a hold rating and four have given a buy rating to the company. According to MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average price target of C$192.00.

Get Our Latest Analysis on KXS

Kinaxis Company Profile

(Get Free Report)

Kinaxis Inc provides cloud-based subscription software for supply chain operations in the United States, Europe, Asia, and Canada. It offers RapidResponse, a cloud-based platform, which provides advanced planning, sales and operation planning, supply and demand planning, inventory management, and command and control center services.

Read More

Insider Buying and Selling by Quarter for Kinaxis (TSE:KXS)

Should You Invest $1,000 in Kinaxis Right Now?

Before you consider Kinaxis, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Kinaxis wasn't on the list.

While Kinaxis currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

3 Bank Stocks Defying Market Turmoil—Cheap Options Trades!
Time to Buy SoFi? Fintech’s Next Big Move
3 Chip Stocks Primed for a Comeback—Have They Found the Bottom?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads